Hjem › Type 2-diabetes › Arizona › Tucson
Type 2-diabetes kliniske forsøg i Tucson, AZ
10 studier for Type 2-diabetes søger deltagere på steder i og omkring Tucson (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- Arizona Clinical Trials, Tucson
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
RekruttererFrivillige med god helbredstilstand velkomne
- Noble Clinical Research, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- Tucson Clinical Research Institute, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruttererFase 3
- Research Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RekruttererFase 3
- Arizona Clinical Trials, Tucson
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RekruttererFase 2
- Arizona Clinical Trials - Broadway, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RekruttererFase 2
- Pima Heart, Tucson
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RekruttererFase 3
- University of Arizona, Tucson
Type 2-diabetes forsøg i andre byer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL24 studier
- Boston, MA20 studier
- Miami, FL19 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- Atlanta, GA17 studier
- San Diego, CA17 studier
- Los Angeles, CA16 studier
Andre studier i Tucson
- Brystkræft20 studier
- Ikke-småcellet lungecancer17 studier
- Overvægt17 studier
- Overvægt15 studier
- Metastatisk cancer14 studier
- Kræft (alle typer)12 studier
- Kardiovaskulær sygdom12 studier
- Colorektal kræft11 studier
- Prostatakræft11 studier
- Steatotisk leversygdom10 studier
- Hjertesvigt10 studier
- Højt blodtryk10 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.